Post-transplantation polyomavirus infections

Citation
S. Boubenider et al., Post-transplantation polyomavirus infections, J NEPHROL, 12(1), 1999, pp. 24-29
Citations number
44
Categorie Soggetti
Urology & Nephrology
Journal title
JOURNAL OF NEPHROLOGY
ISSN journal
11218428 → ACNP
Volume
12
Issue
1
Year of publication
1999
Pages
24 - 29
Database
ISI
SICI code
1121-8428(199901/02)12:1<24:PPI>2.0.ZU;2-2
Abstract
Increasing attention has been recently accorded to BK and JC viruses (BKV a nd JCV), Both these human polyomavirus (HPV) are members of the papovavirus family which includes the simian virus SV 40, BKV and JCV infect more than 60% of the population worldwide. After primary infection, they remain harb oured in the kidneys and may become reactivated in situations of immune imp airment, HPV were first described in 1971, BIN was isolated in a renal tran splant patient with ureteral stricture and JCV in a patient with progressiv e multifocal leukoencephalopathy (PML). BKV was known to be involved in pos t-bone marrow transplantation (BMT) hemorrhagic cystitis, In renal transpla ntation, BKV and JCV were initially found in the post-transplant ureteric s tricture and PML. They are now recognised as a possible cause of transplant interstitial nephritis, mimicking rejection (satisfying the Banff criteria for acute rejection) or drug toxicity, In HPV nephritis there is a mixed i nterstitial inflammatory infiltrate with focal tubular injury; the tubular epithelium shows marked anisonucleosis, nuclear atypia and basophilic or am phophilic intranuclear inclusions. Tubulitis is frequent. DNA hybridisation or gene amplification by polymerase chain reaction usually demonstrate HPV . Although histology with viral nucleic acid detection may be helpful in di fferentiating viral infection and rejection, confusion between these compli cations may lead to either anti-rejection therapy, with the risk of over-im munosuppression, or reduction of immunosuppression, with the risk of graft loss. Confusion may also arise with inclusions of other viruses, such as cy tomegalovirus, herpes virus and adenovirus, Reactivation of BKV and JCV inf ection was demonstrated in respectively 22.2% and 10.9% of renal transplant recipients and 55% and 6.7% of BMT patients. Unfortunately, no routine scr eening is available for these viruses, so this complication is probably und erestimated, No specific therapy of HPV infection is currently available.